Metabolic HealthResearch PaperOpen Access

Higher BMI Lowers Fracture Risk — New Meta-Analysis Rewrites FRAX Calculations

A massive international meta-analysis of 25 cohorts finds higher BMI consistently reduces fracture risk, prompting updates to the FRAX risk tool.

Friday, June 26, 2026 1 view
Published in J Bone Miner Res
An elderly woman stepping onto a medical scale in a clinical exam room, with a bone density scan image visible on a monitor in the background

Summary

A large international meta-analysis pooling data from 25 prospective cohorts found that higher body mass index (BMI) is associated with progressively lower risk of major osteoporotic fractures and hip fractures. Using individual patient data from over 300,000 individuals, the study quantified the graded inverse relationship between BMI and fracture risk after adjusting for age, sex, and bone mineral density. These findings directly inform updates to the FRAX fracture risk assessment tool, which is used globally by clinicians to guide osteoporosis treatment decisions. The results confirm that low BMI remains a meaningful independent risk factor for fracture, while obesity confers a degree of skeletal protection — though this protection does not apply equally to all fracture sites.

Deep Dive Audio
0:00--:--

Detailed Summary

Fracture risk assessment is central to osteoporosis management worldwide, and the FRAX tool — used by clinicians across more than 70 countries — incorporates BMI as one of its key input variables. The original FRAX BMI algorithm was derived from earlier, smaller datasets. This new meta-analysis was conducted specifically to update and validate the BMI component of FRAX using a far larger and more diverse evidence base, ensuring the tool's continued accuracy in contemporary populations facing rising obesity rates.

The study pooled individual participant data from 25 prospective cohort studies contributing data to the FRAX development consortium, encompassing over 300,000 men and women from multiple countries including the United States, United Kingdom, Australia, Sweden, France, and others. Participants had baseline measurements of height and weight (allowing BMI calculation), were followed prospectively for incident fractures, and had data on key covariates. The primary outcomes were major osteoporotic fracture (MOF — comprising hip, clinical spine, forearm, and humerus fractures) and hip fracture specifically. Cox proportional hazards models were used within each cohort, with results pooled using random-effects meta-analysis. Analyses were adjusted for age and, where available, femoral neck bone mineral density (BMD).

The core finding was a robust inverse relationship between BMI and fracture risk across the full BMI spectrum. For every 5 kg/m² increase in BMI, the hazard ratio for major osteoporotic fracture was approximately 0.94 (95% CI: 0.92–0.96) and for hip fracture approximately 0.90 (95% CI: 0.87–0.93), both highly statistically significant. This relationship was present in both men and women, and persisted — though was attenuated — after adjustment for femoral neck BMD, indicating that BMI exerts fracture-protective effects partly through bone density and partly through other mechanisms such as soft tissue padding and altered fall biomechanics. Importantly, the relationship was nonlinear at the extremes: very low BMI conferred substantially elevated risk, while the incremental protective benefit of each additional BMI unit diminished at higher BMI values.

When specific BMI categories were examined, individuals classified as underweight (BMI <18.5 kg/m²) faced dramatically elevated fracture risk — approximately 1.7–2.0 times higher than those with normal BMI (18.5–24.9 kg/m²) for hip fracture. Those in the obese category (BMI ≥30 kg/m²) had meaningfully lower risk than normal-weight individuals, with hazard ratios around 0.75–0.80 for hip fracture. However, the protective effect of obesity was less pronounced for non-hip fractures including ankle and lower leg fractures, where obesity may paradoxically increase risk — a nuance the updated FRAX model accounts for.

For clinical practice, these findings validate and refine the role of BMI in the FRAX algorithm. The updated coefficients will improve fracture risk estimates particularly at the extremes of BMI — for underweight elderly patients (where risk has likely been underestimated) and for obese patients (where risk may have been overestimated in some site-specific analyses). Clinicians should note that even though obesity is associated with lower hip fracture risk, it does not eliminate risk and should not preclude fracture risk assessment. The general public takeaway is that very low body weight in older age carries real bone fracture risk, reinforcing guidance around maintaining adequate nutrition and muscle mass rather than pursuing very low body weight.

Key Findings

  • Each 5 kg/m² increase in BMI was associated with ~6% lower risk of major osteoporotic fracture (HR ≈ 0.94, 95% CI: 0.92–0.96) across 25 pooled cohorts
  • Each 5 kg/m² increase in BMI was associated with ~10% lower hip fracture risk (HR ≈ 0.90, 95% CI: 0.87–0.93), statistically highly significant
  • Underweight individuals (BMI <18.5 kg/m²) had approximately 1.7–2.0 times higher hip fracture risk compared to normal-weight individuals
  • Obese individuals (BMI ≥30 kg/m²) had hip fracture HRs of approximately 0.75–0.80 relative to normal BMI, reflecting meaningful skeletal protection
  • The inverse BMI–fracture relationship persisted after adjustment for femoral neck bone mineral density, indicating BMI has fracture-risk effects beyond just its effect on bone density
  • The protective effect of higher BMI was site-specific and less pronounced or absent for ankle/lower limb fractures, where obesity may paradoxically increase risk
  • Findings directly inform updated FRAX algorithm coefficients deployed globally in >70 countries for clinical fracture risk assessment

Methodology

This was an individual participant data meta-analysis pooling data from 25 prospective cohort studies within the FRAX development consortium, involving over 300,000 men and women from multiple countries. Cox proportional hazards models were fitted within each cohort and results combined using random-effects meta-analysis. Primary outcomes were incident major osteoporotic fracture and hip fracture; analyses were adjusted for age and, where available, femoral neck BMD to decompose direct and BMD-mediated BMI effects. Non-linear dose-response relationships were explored using restricted cubic splines.

Study Limitations

The meta-analysis relied on self-reported or single-occasion measured height and weight in many cohorts, introducing measurement error and failing to capture BMI changes over follow-up. Cohorts were predominantly from high-income Western countries, limiting generalizability to Asian, African, or low-income populations. Several authors disclosed relationships with pharmaceutical companies involved in osteoporosis therapeutics, representing potential conflicts of interest.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: